학술논문
Liver damage due to alendronate.
Document Type
Case Study
Source
Subject
*LETTERS to the editor
*DRUGS
*
Language
ISSN
0028-4793
Abstract
A letter to the editor is presented which discusses issues related to the drug alendronate, which is given for the treatment of postmenopausal women with osteoporosis and patients with glucocorticoid-induced osteoporosis.